MEDVASC – Semaglutide : multiples effets
Blog du Dr Jean-Pierre LAROCHE, médecin vasculaire sans filtre et pragmatique qui parle de Médecine Vasculaire et de l’actualité
Related Articles
Cardiac rehabilitation: the gateway for secondary prevention
Cardiac rehabilitation (CR) is a multidisciplinary supervised programme which typically consists of tailored exercise and education on lifestyle management and risk factor modification in cardiac…
Atrial Fibrillation: AI being trialled to spot heart condition
The tool scours GP records to look for signs a patient is at risk of developing atrial fibrillation.
1974 Hesketh James Hunt – Monaco Historic GP 2021 Onboard
Car : Hesketh 1974 – James HuntDriver : Jean-Denis Delétraz (My father)Owner : GPX Historic https://www.gpextreme.com/gpx-historicOnboard of the start & firs…
Hospital and Ambulatory Care Settings
For more than 25 years, ACC’s suite of NCDR registries have been helping hospitals, health systems, centers and practices by providing data-driven insights, analysis and…
Home – Fisher House Foundation
What are the requirements to stay at a Fisher House? How do I reserve a room? Fisher Houses are given to the military services and…
Top 10 ingredients for quick and healthy meals
Here are the 10 best ingredients and 25 ways to mix and match them for tasty, heart-healthy meals. Get easy ideas for breakfast, lunch, dinner…
3 myths about bone health
Strong bones play a vital role in overall health — supporting us, protecting our organs, securing muscles and storing essential minerals. As bones weaken, they…
(1) Magenta Elevate Hight Output Pump in High Risk PCI by Heart Corner: Innovations in Cardiovascular Science
This JACC manuscript details a first-in-human study evaluating the Magenta Elevate, a novel high-output mechanical circulatory support (MCS) catheter. The study assessed its safety and…
CAR-T cell therapies for T cell malignancies: does cellular immunotherapy represent the best chance of cure?
Chimeric antigen receptor T cell (CAR-T) therapy has proven successful for B cell lymphomas and leukaemias. This success has inspired the development of CA
Durability of transcatheter aortic valve implantation
Comprehensive overview of bioprosthetic valve dysfunction and failure following TAVI and SAVR, with a focus on structural valve deterioration.
